France Approves Illuccix PSMA-PET Imaging for Prostate Cancer
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that...